Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group. [electronic resource] by
- Lorusso, D
- Ferrandina, G
- Pignata, S
- Ludovisi, M
- Viganò, R
- Scalone, S
- Scollo, P
- Breda, E
- Pietragalla, A
- Scambia, G
Producer: 20100224
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 21
Availability: No items available.
|
|
6.
|
|
|
7.
|
Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients. [electronic resource] by
- Lorusso, D
- Scambia, G
- Amadio, G
- di Legge, A
- Pietragalla, A
- De Vincenzo, R
- Masciullo, V
- Di Stefano, M
- Mangili, G
- Citterio, G
- Mantori, M
- Lambiase, A
- Bordignon, C
Producer: 20120907
In:
British journal of cancer vol. 107
Availability: No items available.
|
|
8.
|
Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial. [electronic resource] by
- Lorusso, D
- Ferrandina, G
- Colombo, N
- Pignata, S
- Pietragalla, A
- Sonetto, C
- Pisano, C
- Lapresa, M T
- Savarese, A
- Tagliaferri, P
- Lombardi, D
- Cinieri, S
- Breda, E
- Sabatucci, I
- Sabbatini, R
- Conte, C
- Cecere, S C
- Maltese, G
- Scambia, G
Producer: 20191219
In:
Gynecologic oncology vol. 155
Availability: No items available.
|